GUTS: Fractyl Health Inc

GUTS News

• 12:43 This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - CoreWeave (NASDAQ:CRWV), Biomea Fusion (NASDAQ:BMEA)
• 11:32 Canaccord Genuity lowers Fractyl Health stock price target to $6 from $12
• 20:12 Fractyl Health raises $23 million in public offering with warrants
• 20:30 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19%
• 17:38 Nasdaq Surges 1%; Uber Sales Top Estimates - Ainos (NASDAQ:AIMD), Astera Labs (NASDAQ:ALAB)
• 14:50 Fractyl Health stock plunges after $20 million public offering
• 13:46 US Stocks Edge Higher; McDonald's Posts Upbeat Earnings - Ainos (NASDAQ:AIMD), Fractyl Health (NASDAQ:GUTS)
• 12:41 Fractyl Health prices $20 million public offering of common stock
• 09:35 Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Astera Labs (NASDAQ:ALAB), Digital Turbine (NASDAQ:APPS)
• 20:21 Fractyl Health announces proposed public offering of common stock
• 20:09 Fractyl’s Revita procedure shows durable weight loss in diabetes patients
• 11:08 Canaccord Genuity reiterates Buy rating on Fractyl Health stock
• 14:13 Fractyl Health: Speculative Buy With Binary Risk (NASDAQ:GUTS)
• 11:55 Fractyl Health stock maintains Buy rating at Canaccord on positive trial data
• 18:53 Fractyl Health Stock Is Trading Lower Monday: What's Going On? - Fractyl Health (NASDAQ:GUTS)
• 16:22 Fractyl Health stock steady as Evercore ISI reiterates outperform rating
• 11:45 Fractyl reports positive 3-month data for post-GLP-1 weight maintenance
• 11:44 Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type
• 11:13 Fractyl Health receives two new patents for duodenal resurfacing tech
• 11:12 Fractyl Health to Present New Preclinical Data from its Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Platform at the American Diabetes Association’s 85th Scientific Sessions
• 11:46 Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita ® Across its Bariatric and Metabolic Endoscopy Centers Nationwide
• 11:12 Fractyl Health advances gene therapy for diabetes treatment
• 11:28 Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
• 01:01 Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript